Methylxanthines in Asthma
- 19 August 2010
- book chapter
- Published by Springer Nature
- No. 200,p. 439-456
Abstract
Methylxanthines represent a unique class of drugs for the treatment of asthma. The methylxanthine theophylline has demonstrated efficacy in attenuating the three cardinal features of asthma – reversible airflow obstruction, airway hyperresponsiveness, and airway inflammation. At doses achieving relatively high serum levels in which toxic side effects are sometimes observed, direct bronchodilatory effects of theophylline are recognized. At lower serum concentrations, theophylline is a weak bronchodilator but retains its capacity as an immunomodulator, anti-inflammatory, and bronchoprotective drug. Intense investigation into the molecular mechanisms of action of theophylline has identified several different points of action. Phosphodiesterase inhibition and adenosine receptor antagonism have both been implicated in promoting airway smooth muscle relaxation and bronchodilation. Similar mechanisms of action may explain the inhibitory effects of theophylline on immune cells. At lower concentrations that fail to inhibit phosphodiesterase, effects on histone deacetylase activity are believed to contribute to the immunomodulatory actions of theophylline. Since anti-inflammatory and immunomodulatory effects of methylxanthines are realized at lower serum concentrations than are required for bronchodilation, theophylline’s predominant role in asthma treatment is as a controller medication for chronic, persistent disease.Keywords
This publication has 96 references indexed in Scilit:
- Caffeine induces Ca2+ release by reducing the threshold for luminal Ca2+ activation of the ryanodine receptorBiochemical Journal, 2008
- Global strategy for asthma management and prevention: GINA executive summaryEuropean Respiratory Journal, 2007
- Cross-Talk between Gs- and Gq-Coupled Pathways in Regulation of Interleukin-4 by A2B Adenosine Receptors in Human Mast CellsMolecular Pharmacology, 2006
- Inhibition of CD44, CD45 and LFA-3 mediated cytokine release from human monocytes by SK&F 86002 and pentoxifyllineInternational Journal of Immunopharmacology, 1993
- Adenosine-induced bronchoconstriction in an allergic rabbit model: Antagonism by theophylline aerosolInflammation Research, 1992
- Effects of enprofylline and theophylline may show the role of adenosineLife Sciences, 1986
- Effects of Theophylline on Diaphragmatic Strength and Fatigue in Patients with Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 1984
- Mechanism of respiratory effects of methylxanthinesRespiration Physiology, 1983
- Aminophylline Improves Diaphragmatic ContractilityNew England Journal of Medicine, 1981
- Klinischer und Experimenteller Beitrag zur Krampflösenden Wirkung der PurinderivateJournal of Molecular Medicine, 1922